Author

Jean-Frederic Colombel 1

1 Icahn School of Medicine a

A COMBINATION OF CLINICAL, SEROLOGICAL AND GENETIC FACTORS PREDICTS COMPLICATED DISEASE COURSE IN PAEDIATRIC-ONSET CROHN'S DISEASE: RESULTS FROM A POPULATION-BASED STUDY

Hélène Sarter, Guillaume Savoye, Dominique Turck, Francis Vasseur, Guillemette Marot, Benjamin Pariente, Jean-Frederic Colombel, Corinne Gower-Rousseau, Mathurin Fumery

A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY TO EXPLORE THE EFFICACY OF ORAL GED-0301 (MONGERSEN) ON ENDOSCOPIC ACTIVITY AND CLINICAL EFFECTS IN BOTH TNF-NAIVE AND TNF-EXPERIENCED SUBJECTS WITH ACTIVE CROHN?S DISEASE

Brian G. Feagan, Bruce E. Sands, Guillermo Rossiter, Xiaobin Li, Keith Usiskin, Xiaojiang Zhan, Jean-Frederic Colombel

A TREAT TO TARGET APPROACH DECREASES THE RATE OF CD-RELATED ADVERSE OUTCOMES VERSUS A CLINICAL APPROACH IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE CROHN'S DISEASE: DATA FROM CALM

Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Filip Baert, T. Vanásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hebuterne, Simon Travis, Silvio Danese, Walter Reinisch, William Sandborn, Paul Rutgeerts, Daniel W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Wan J Le

AbbVie - Are we ready to change the course of IBD?

Edouard Louis, Remo Panaccione, Laurent Peyrin-Biroulet, Jean-Frederic Colombel

Amgen - The emerging treatment landscape of IBD: role of innovator biologics and biosimilars (Amgen Europe GmbH)

Alessandro Armuzzi, Jean-Frederic Colombel, Walter Reinisch

ANTI-TNFΑ TREATMENT EFFICACY IN PREVENTION OF POSTOPERATIVE RECURRENCE IN CROHN’S DISEASE DEPENDS ON PREVIOUS EXPOSURE TO ANTI-TNFΑ AGENTS

Michael Collins, Hélène Sarter, Corinne Gower-Rousseau, Dine Koriche, Maria Nachury, Louise Libier, Antoine Cortot, Philippe Zerbib, Jean-Frederic Colombel, Laurent Peyrin-Biroulet, Pierre Desreumaux, Guillaume Pineton de Chambrun

Association of Ustekinumab Serum Concentrations and Perianal Fistula Resolution in the Crohn's Disease UNITI Program

Bruce E. Sands, Brian Kramer, Christopher Gasink, Douglas Jacobstein, Long-Long Gao, Tony Ma, Joseph Adedokun, Jean-Frédéric Colombel, David A Schwartz

AZATHIOPRINE DOSE REDUCTION  INFLAMMATORY BOWEL DISEASE PATIENTS ON COMBINATION THERAPY: A PROSPECTIVE STUDY

Emilie Del Tedesco, Stéphane Paul, hubert marotte, Nicolas Williet, Jean Marc Phelip, Laurent Peyrin-Biroulet, Jean-Frederic Colombel, Xavier Roblin

CALPROTECTIN IS LESS ACCURATE THAN MAYO ENDOSCOPY SCORE TO MONITOR CONTINUOUS CLINICAL RESPONSE IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Walter Reinisch, Jean-Frederic Colombel, Ahmed Khalifa, Ruji Yao, Susan Huyck, George Philip, Freddy Cornillie

CANCER IN ELDERLY-ONSET INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED STUDY

halima cheddani, Mathurin Fumery, Julia Salleron, Anne-Marie Bouvier, Jean-Louis Dupas, Eric Lerebours, Laurent Peyrin-Biroulet, Jean-Frederic Colombel, Guillaume Savoye, Corinne Gower-Rousseau, Corinne Gower-Rousseau

Item 1 - 10 / 159
1
2 3 4 5 6 7
...
15 16